Dow Down 0.25% Nasdaq Down 0.14%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM
0.77 Sep 29, 4:00PM EDT
Prev Close:0.77
Open:0.78
Bid:N/A
Ask:1.35 x 1000
1y Target Est:2.00
Beta:0.86
Next Earnings Date:N/A
Day's Range:0.74 - 0.80
52wk Range:0.39 - 4.91
Volume:111,798
Avg Vol (3m):99,834
Market Cap:9.76M
P/E (ttm):N/A
EPS (ttm):-1.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECTE

Comparison

Symbol% ChgMkt Cap
ECTE 0.00%9.76M
ABT63.00B
DXCM3.12B
MDT61.26B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):471.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.19
Quarterly EPS Est (Sep-14) :-0.31
Mean Recommendation*:5.0
PEG Ratio (5 yr expected):-0.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Echo Therapeutics, Inc. is engaged in the development of transdermal skin permeation and diagnostic medical devices. It is developing Symphony CGM system (Symphony), a needle-free wireless continuous glucose monitoring system for use in hospital c... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback